NUREMBERG--(BUSINESS WIRE)--Recognizing pharmaceutical manufacturers’ expanding needs for cost-effective syndicated research insights to support market assessment and brand strategy in the growing BRIC markets, GfK HealthCare announced it will build upon its long-standing U.S. syndicated offering, Therapeutic Class Dynamics™ (TCD) physician studies, to offer further local market treatment perspectives. The new studies cover Brazil, Russia, India and China and include detailed perspectives across several indications within cardiovascular, psychiatry, respiratory and rheumatology/pain.
